Biosafe Inc is categorized under Commercial Biotechnical Research in Pittsburgh, PA and active since 1997.
Biosafe Inc was established in 1997, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Max Fedor at the company’s single location by writing to 2545 Penn Avenue Apartment 1, Pittsburgh, Pennsylvania PA 15222 or by phoning (412) 770-1302. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Biosafe Inc |
| Contact Person: | Max Fedor |
| Address: | 2545 Penn Avenue Apartment 1, Pittsburgh, Pennsylvania 15222 |
| Phone Number: | (412) 770-1302 |
| Website Address: | shop.biosafe.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Biosafe Inc was started in 1997 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Max Fedor for inquiries that concern Biosafe Inc by calling the company number (412) 770-1302, as your correspondence is most welcome. Additionally, the physical location of the single location of Biosafe Inc can be found at the coordinates 40.454868,-79.978793 as well as the street address 2545 Penn Avenue Apartment 1 in Pittsburgh, Pennsylvania 15222.
For its online presence, you may visit Biosafe Inc’s website at shop.biosafe.com and engage with its social media outlets through on Twitter and on Facebook.